Welcome to our dedicated page for Digital Health Acquisition news (Ticker: DHAC), a resource for investors and traders seeking the latest updates and insights on Digital Health Acquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Digital Health Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Digital Health Acquisition's position in the market.
VSee Health (Nasdaq: VSEE) has partnered with Stand Together to launch Aimee, an innovative telehealth service in Wichita, Kansas. Aimee offers virtual healthcare, labs, and prescription drug services accessible to patients regardless of insurance status. The service transforms local community centers into care hubs, providing virtual urgent care, primary care, and medical weight loss programs.
Aimee aims to improve healthcare access and affordability, with a monthly subscription of $4.99, virtual urgent care visits at $9.99, and primary care appointments at $29.99. This initiative addresses healthcare gaps in underserved communities and seeks to improve health outcomes. The service was officially launched on July 13th at a local community event in Wichita.
VSee Health (Nasdaq: VSEE) and Ava Robotics have partnered to develop telepresence solutions for the hospital inpatient intensive care market. The collaboration involves creating a VSee-powered Ava robot that enables providers to deliver personalized care remotely. This autonomous robot will operate in hospital ICUs, allowing skilled physicians to have a physical presence at the point of care, interact with patients, consult with onsite staff, and make real-time treatment decisions.
The initiative aims to expand telehealth accessibility beyond major metropolitan hospitals to regional and smaller ICUs. Dr. Imo Aisiku, co-CEO and Chairman of VSee Health, emphasized that this partnership will make world-class critical care available to every ICU in the country, potentially improving patient outcomes, reducing transfers, and lowering costs associated with critical care and stroke treatment.
VSee Health (NASDAQ: VSEE) has partnered with SkywardRx to provide telehealth and billing services to SkywardRx's clients, including nonprofits, hospitals, and Fortune 20 corporations. This collaboration aims to optimize patient access in critical healthcare areas such as behavioral health, nutritional wellness, and substance abuse, while reducing overall healthcare costs for both patients and providers.
The partnership has the potential to expand VSee's services to approximately five million patients served by SkywardRx and their clients. By combining VSee's turnkey technology and billing services with SkywardRx's personal consulting services, the companies aim to improve healthcare delivery and access for vulnerable patient populations.
VSee Health (Nasdaq: VSEE) has announced that its subsidiary, iDoc Telehealth Solutions, will provide outpatient specialty medical services to the Federal Bureau of Prisons (BOP). The partnership with Seven Corners Correctional Health will initially cover four federal prisons: FCI Williamsburg in South Carolina, FCI Loretto in Pennsylvania, FDC SeaTac in Washington, and FCI Bastrop in Texas. This initiative aims to offer inmates quality, accessible healthcare, optimizing resource utilization and reducing costs. Specialties include cardiology, nephrology, gastroenterology, psychiatry, and more. The collaboration underscores VSee Health's commitment to advancing telemedicine in correctional settings.
Summary not available.
Summary not available.
Summary not available.
Digital Health Acquisition Corp. (NASDAQ: DHAC) announced an extension of its initial business combination deadline from February 8, 2023, to May 8, 2023. This marks the first of three potential three-month extensions allowed by the governing documents, granting the company additional time to finalize its merger with target companies, including VSee Labs, a telehealth solution provider, and iDoc Virtual Telehealth Solutions, focusing on acute care via telehealth. Digital Health raised $115 million during its IPO in November 2021 to acquire scalable healthcare businesses.
Digital Health Acquisition Corp. (NASDAQ:DHAC) has filed a definitive proxy statement to hold a special stockholder meeting on October 20, 2022, aiming to extend the deadline for an initial business combination from November 8, 2022 to February 8, 2023. The proposal allows for up to three additional three-month extensions, provided the sponsor pays $350,000 for each extension. If approved, the per-share portion of the trust account is estimated at $10.21.
The company recently amended its business combination agreement with VSee Labs and iDoc, now consisting solely of common stock shares for the merger.
Digital Health Acquisition Corporation (NASDAQ: DHAC) has signed a definitive agreement to acquire VSee Lab, Inc. and iDoc Telehealth Solutions, creating VSee Health, Inc. The merger, valued at approximately $110 million, aims to enhance telehealth capabilities and expand market reach. VSee offers a customizable, HIPAA-compliant SaaS platform, while iDoc specializes in neurocritical care. Completion of the transaction is anticipated in Q3 2022, pending shareholder approval and regulatory conditions.